Corresponding author: Dr. R. Dal-Ré.Medical Department. GlaxoSmithKline SA.Parque Tecnológico de Madrid.C/ Severo Ochoa, 2. 28760 Tres Cantos. Madrid. Spain
was read the article
array:23 [ "pii" => "S0025775304746631" "issn" => "00257753" "doi" => "10.1016/S0025-7753(04)74663-1" "estado" => "S300" "fechaPublicacion" => "2004-10-01" "aid" => "74663" "copyright" => "Elsevier España, S.L.. All rights reserved" "copyrightAnyo" => "2004" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2004;123:770-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 521 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 337 "PDF" => 177 ] ] "itemSiguiente" => array:18 [ "pii" => "S0025775304746643" "issn" => "00257753" "doi" => "10.1016/S0025-7753(04)74664-3" "estado" => "S300" "fechaPublicacion" => "2004-10-01" "aid" => "74664" "copyright" => "Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "err" "cita" => "Med Clin. 2004;123:774" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3341 "formatos" => array:3 [ "EPUB" => 5 "HTML" => 2843 "PDF" => 493 ] ] "es" => array:6 [ "idiomaDefecto" => true "titulo" => "Fe de errores" "tienePdf" => "es" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "774" ] ] "contienePdf" => array:1 [ "es" => true ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775304746643?idApp=UINPBA00004N" "url" => "/00257753/0000012300000020/v1_201307291640/S0025775304746643/v1_201307291640/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S002577530474662X" "issn" => "00257753" "doi" => "10.1016/S0025-7753(04)74662-X" "estado" => "S300" "fechaPublicacion" => "2004-10-01" "aid" => "74662" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2004;123:766-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 5313 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 4749 "PDF" => 556 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Hiperleptinemia como factor de riesgo en hipertensión arterial asociada a obesidad" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "766" "paginaFinal" => "769" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Hyperleptinemia as a risk factor in obesity-related hypertension" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:2 [ 0 => array:2 [ "autoresLista" => "Cleto álvarez-Aguilara, I Lourdes Mondragón-Jiménez, Anel Gómez-Garcíac, Ramón Paniagua-Sierrad, Dante Amatod" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Cleto" "apellidos" => "álvarez-Aguilara" ] 1 => array:2 [ "nombre" => "I" "apellidos" => "Lourdes Mondragón-Jiménez" ] 2 => array:2 [ "nombre" => "Anel" "apellidos" => "Gómez-Garcíac" ] 3 => array:2 [ "nombre" => "Ramón" "apellidos" => "Paniagua-Sierrad" ] 4 => array:2 [ "nombre" => "Dante" "apellidos" => "Amatod" ] ] ] 1 => array:2 [ "autoresLista" => "Jesús Ramírez-Enríquez" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jesús" "apellidos" => "Ramírez-Enríquez" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577530474662X?idApp=UINPBA00004N" "url" => "/00257753/0000012300000020/v1_201307291640/S002577530474662X/v1_201307291640/es/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Nature and extent of changes in the patient's information sheets of international multicentre clinical trials as requested by Spanish Research Ethics Committees" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "770" "paginaFinal" => "774" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Rafael Dal-Ré, Elena Morejón, Rafael Ortega" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Rafael" "apellidos" => "Dal-Ré" "email" => array:1 [ 0 => "rafael.dal-re@gsk.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">**</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Elena" "apellidos" => "Morejón" ] 2 => array:2 [ "nombre" => "Rafael" "apellidos" => "Ortega" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Medical Department. GlaxoSmithKline SA. Tres Cantos. Madrid. Spain" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "**" "correspondencia" => "Corresponding author: Dr. R. Dal-Ré.Medical Department. GlaxoSmithKline SA.Parque Tecnológico de Madrid.C/ Severo Ochoa, 2. 28760 Tres Cantos. Madrid. Spain" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tipo y magnitud de los cambios requeridos por los Comités Éticos de Investigación Clínica en las hojas de información para el paciente en los ensayos clínicos multicéntricos internacionales" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words" "identificador" => "xpalclavsec222459" "palabras" => array:5 [ 0 => "Multicentre clinical trials" 1 => "Informed consent" 2 => "Patient's information sheet" 3 => "Research ethics committees" 4 => "Requested changes" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec222460" "palabras" => array:5 [ 0 => "Ensayos clínicos multicéntricos" 1 => "Consentimiento informado" 2 => "Hoja de información para el paciente" 3 => "Comités éticos de investigación clínica" 4 => "Cambios solicitados" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Background and objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">In the assessment of every clinical trial protocol, one of the critical tasksperformed by research ethics committees (RECs) is an in depth review of the patient's informationsheet (PIS). The objective of the study was to review the assessment of RECs in Spain regarding thePIS through the changes to be done in them in order to obtain RECs approval. Differences betweenchanges requested by different RECs may provide some measure of the existing homogeneity amongstRECs as far as evaluation of PIS is concerned</p> <span class="elsevierStyleSectionTitle">Material and method</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">This was a prospective study of 187 applications of multinational clinical trials (MCT)submitted in 2002-03 and for which the RECs and Spanish Medicines Agency evaluation process wascompleted by July 2003, reviewed by 62 RECs, for 85 hospitals and 29 primary care centres. The mainassessment measures were PIS-related features and type of changes asked by RECs to be done in PIS</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">One hundred and one of 183 approved applications of 24 protocols submitted had 307queries raised from 41 RECs, of which 118 were related with changes in PIS. These 118 queries wereraised by 38 RECs (61%; 38/62) in 66 applications (36%; 66/183). There were queries for all 24protocols, but only for 2 studies (8%; 2/24) there were no queries related with PIS. In seven protocolsall queries were associated with the PIS (29%; 7/24). 22% of RECs asked for a median of 14.5 copiesof a separate PIS (in addition to those submitted with the protocol and the rest of documentation) forthe assessment of the MCT. The number of pages of the PIS ranged from 3 to 6 with a mean number of2,082 words. The type of changes in the PIS requested by the RECs were related with: risk/benefit andadverse events (27.1%), typographic changes and logistics information (19.5%), personal dataprotection (16.9%), explanation of procedures (11.9%), add some information (11.9%), word/sentencedifficult to understand (8.5%) and delete some information (4.2%)</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">In this study, the general content and quality of the PIS were correct enough. Indeed,although the number of RECs asking for changes in the PIS was not low (61%), most of thesechanges were minor and affected only 36% of the submissions, with a median of 1 change persubmission. Therefore, these data also suggest that there is a remarkable homogeneity across RECs intheir evaluation of PIS. RECs have special interest in such aspects as benefit/risk information andconfidentiality and data protection; in fact, almost half of the changes in PIS requested by RECsreferred to those two items</p>" ] "es" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Fundamento y objetivo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Una de las tareas clave en la evaluación por los Comités Éticos de InvestigaciónClínica (CEIC) de cada protocolo de ensayo clínico es la revisión en profundidad de la hoja de informaciónpara el paciente (HIP). El objetivo de este estudio fue revisar la evaluación de las HIP realizadapor los CEIC en España, a través de los cambios requeridos para obtener su aprobación. Lasdiferencias en los cambios solicitados pueden dar una medida del grado de homogeneidad existenteentre los CEIC en la evaluación de HIP</p> <span class="elsevierStyleSectionTitle">Material y método</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Es un estudio prospectivo de 187 solicitudes de ensayos multicéntricos (MCT) sometidosen 2002-2003 y para los que el proceso completo de evaluación por CEIC y la Agencia Española delMedicamento estaba completado en julio de 2003, revisados por 62 CEIC, para ensayos a realizar en 85hospitales y 29 centros de atención primaria. Las variables principales de evaluación fueron las característicasrelacionadas con las HIP y tipo de modificaciones solicitadas por los CEIC a realizar en las HIP</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">En 101 de las 183 solicitudes aprobadas pertenecientes a 24 protocolos sometidos, 41 CEICrequirieron 307 aclaraciones, de las que 118 estaban relacionadas con las HIP. Estas 118 modificacionesfueron solicitadas por 38 CEIC (61%; 38/62), en 66 solicitudes (36%; 66/183). Se requirieron aclaracionesen todos los protocolos, pero en sólo 2 (8%; 2/24) de ellos no se solicitó modificación alguna en laHIP. El 22% de los CEIC solicitaron una mediana de 14,5 copias adicionales de la HIP (además de laspresentadas con el protocolo y el resto de la documentación del ensayo), para la evaluación del ensayoMCT. El número de páginas de las HIP varió de 3 a 6, con una media de 2.082 palabras. El tipo de modificacionesrequerido por los CEIC estaba relacionado con: riesgo/beneficio y acontecimientos adversos(27,1%), cambios tipográficos e información logística (19,5%), protección de datos personales (16,9%),explicación de los procedimientos (11,9%), añadir algún tipo de información (11,9%), dificultad de entendimientode palabra/frase (8,5%) y suprimir algún tipo de información (4,2%)</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">En este estudio, el contenido general y la calidad de las HIP fue suficientemente correcta yaque aunque el número de CEIC que solicitaron modificaciones no es bajo (61%), la mayor parte de los cambiosfueron menores y afectaron sólo al 36% de las solicitudes presentadas, con una mediana de 1 cambiopor solicitud. Estos datos sugieren que existe una notable homogeneidad en la evaluación de las HIP entreCEIC. Los CEIC tienen un interés especial en la información del riesgo/beneficio y la confidencialidad y laprotección de datos, ya que casi la mitad de los cambios requeridos se refieren a estos aspectos</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:22 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "RJ Levine" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "1986" "editorial" => "Urban & Schwarzenberg" "editorialLocalizacion" => "Balti-more" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:1 [ "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "1996" "editorial" => "IFPMA" "editorialLocalizacion" => "Geneva" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Food and Drug Administration. 21 CFR 50. Informed consent of human subjects. www.accessdatahttp://www.accessdata. fda.gov (accessed on october 6th, 2003)" ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Readability of informed consent forms for research in a Veterans Administration Medical Center" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "MT Baker" 1 => "HA Taub" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1983" "volumen" => "250" "paginaInicial" => "2646" "paginaFinal" => "2648" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6632164" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Informed consent to biomedical research in Veterans Administration Hospitals" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "HW Riecken" 1 => "R Ravish" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1982" "volumen" => "248" "paginaInicial" => "344" "paginaFinal" => "348" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7045434" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Are patient consent forms for research protocols easy to read?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "KA Priestley" 1 => "C Campbell" 2 => "CB Valentine" 3 => "DM Denison" 4 => "NP Buller" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1992" "volumen" => "305" "paginaInicial" => "1263" "paginaFinal" => "1264" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1477569" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Can the written information to research subjects be improved? An empiric study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "E Bjorn" 1 => "P Rossel" 2 => "S Holm" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Med Ethics" "fecha" => "1999" "volumen" => "25" "paginaInicial" => "263" "paginaFinal" => "267" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10390684" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Readability standards for informed-consent forms compared with actual readability" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "MK Paasche-Orlow" 1 => "HA Taylor" 2 => "FL Brancati" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMsa021212" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2003" "volumen" => "348" "paginaInicial" => "721" "paginaFinal" => "726" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12594317" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Performance of research ethics committees in Spain. A prospective study of 100 applications for clinical trial protocols on medicines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R Dal-Re" 1 => "J Espada" 2 => "R Ortega" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Med Ethics" "fecha" => "1999" "volumen" => "25" "paginaInicial" => "268" "paginaFinal" => "273" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10390685" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The new system of review of multicentre research ethics committees: a prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J Tully" 1 => "N Ninis" 2 => "R Boody" 3 => "R Viner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2000" "volumen" => "320" "paginaInicial" => "1179" "paginaFinal" => "1182" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10784541" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acceptability and profile of the clinical drug trials underway in Finnish university hospi tals in the 1990s: Applications reviewed by Ethics Committees" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T Keinonen" 1 => "S Nieminen" 2 => "V Saareks" 3 => "V Saano" 4 => "P Ylitalo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Meth Find Exper Clin Pharmacol" "fecha" => "2001" "volumen" => "23" "paginaInicial" => "415" "paginaFinal" => "423" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Observational study of 353 applica tions to London multicentre research ethics committee 1997-2000" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M Boyce" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2002" "volumen" => "325" "paginaInicial" => "1081" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12424169" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Responses by four local research ethics committees to submitted proposals" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "G Kent" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Med Ethics" "fecha" => "1999" "volumen" => "25" "paginaInicial" => "274" "paginaFinal" => "277" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10390686" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Real Decreto 561/1993, de 16 de abril, por el que se establecen los requisitos para la realización de ensayos clínicos con medicamentos. BOE de 13 de mayo de 1993" ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Análisis de las hojas de información al paciente para la obtención de su consentimiento informado en ensayos clínicos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "JP Ordovas" 1 => "E López" 2 => "E Urbieta" 3 => "R Torregrosa" 4 => "NV Jiménez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1999" "volumen" => "112" "paginaInicial" => "90" "paginaFinal" => "94" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ley Orgánica 15/1999, de 13 de diciembre, de Protección de datos de Carácter Personal. BOE de 14 de diciembre de 1999" ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data on the free movement of such data. Official Journal L 281, 23rd November 1995; p. 31-50" ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Propuesta de aplicación de la Ley de protección de datos de carácter personal en las hojas de información y consentimiento de los participantes en los ensayos clínicos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R Dal-Ré" 1 => "C Gómez-Piqueras" 2 => "F García-Alonso" 3 => "A Luque" 4 => "R Avilés" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2001" "volumen" => "117" "paginaInicial" => "751" "paginaFinal" => "756" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The ethical conduct of health services research: a case study of 55 institutionsâ'™ applications to the SUPPORT project" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J Lynn" 1 => "J Johnson" 2 => "RJ Levine" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Res" "fecha" => "1994" "volumen" => "42" "paginaInicial" => "3" "paginaFinal" => "10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8200185" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Variation in institutional review board responses to a standard protocol for a multicenter clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "TO Stair" 1 => "CR Reed" 2 => "MS Radeos" 3 => "G Koski" 4 => "CA Camargo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acad Emerg Med" "fecha" => "2001" "volumen" => "8" "paginaInicial" => "636" "paginaFinal" => "641" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11388939" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Variability among institutional review boardsâ'™ decisions within the context of a multicenter trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H Silverman" 1 => "SC Hull" 2 => "J Sugarman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "2001" "volumen" => "29" "paginaInicial" => "235" "paginaFinal" => "241" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11246299" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effects of local review on informed consent documents from a multicenter clinical trials consortium" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W Burman" 1 => "P Breese" 2 => "S Weis" 3 => "N Bock" 4 => "J Bernardo" 5 => "A Vernon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Control Clin Trials" "fecha" => "2003" "volumen" => "24" "paginaInicial" => "245" "paginaFinal" => "255" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12757991" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00257753/0000012300000020/v1_201307291640/S0025775304746631/v1_201307291640/en/main.assets" "Apartado" => array:4 [ "identificador" => "24087" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Original breve" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00257753/0000012300000020/v1_201307291640/S0025775304746631/v1_201307291640/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775304746631?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 0 | 1 | 1 |
2024 October | 0 | 3 | 3 |
2024 September | 0 | 10 | 10 |
2024 August | 0 | 5 | 5 |
2024 July | 0 | 7 | 7 |
2024 June | 0 | 11 | 11 |
2024 May | 0 | 4 | 4 |
2024 April | 0 | 19 | 19 |
2024 March | 0 | 3 | 3 |
2024 February | 0 | 8 | 8 |
2024 January | 0 | 10 | 10 |
2023 December | 0 | 9 | 9 |
2023 November | 0 | 1 | 1 |
2023 October | 0 | 8 | 8 |
2023 September | 0 | 5 | 5 |
2023 August | 0 | 8 | 8 |
2023 July | 0 | 35 | 35 |
2023 June | 0 | 3 | 3 |
2023 May | 0 | 2 | 2 |
2023 April | 0 | 3 | 3 |
2023 March | 1 | 4 | 5 |
2023 February | 0 | 8 | 8 |
2023 January | 0 | 2 | 2 |
2022 December | 0 | 4 | 4 |
2022 November | 0 | 6 | 6 |
2022 October | 0 | 6 | 6 |
2022 September | 0 | 7 | 7 |
2022 August | 0 | 9 | 9 |
2022 July | 0 | 7 | 7 |
2022 June | 0 | 6 | 6 |
2022 May | 0 | 2 | 2 |
2022 April | 0 | 11 | 11 |
2022 February | 0 | 2 | 2 |
2022 January | 0 | 1 | 1 |
2021 December | 0 | 10 | 10 |
2021 August | 0 | 9 | 9 |
2021 June | 0 | 4 | 4 |
2021 April | 0 | 4 | 4 |
2021 March | 0 | 2 | 2 |
2021 February | 0 | 4 | 4 |
2021 January | 0 | 3 | 3 |
2020 December | 0 | 2 | 2 |
2020 November | 0 | 2 | 2 |
2020 October | 0 | 1 | 1 |
2020 September | 0 | 5 | 5 |
2020 August | 0 | 1 | 1 |
2020 July | 0 | 4 | 4 |
2020 June | 0 | 1 | 1 |
2020 April | 0 | 1 | 1 |
2020 March | 0 | 4 | 4 |
2020 February | 0 | 1 | 1 |
2020 January | 0 | 6 | 6 |
2019 December | 0 | 19 | 19 |
2019 November | 0 | 1 | 1 |
2019 September | 0 | 7 | 7 |
2019 July | 0 | 10 | 10 |
2019 June | 0 | 11 | 11 |
2019 May | 0 | 13 | 13 |
2019 April | 0 | 17 | 17 |
2019 March | 0 | 1 | 1 |
2019 February | 0 | 8 | 8 |
2018 December | 0 | 5 | 5 |
2018 November | 0 | 3 | 3 |
2018 October | 0 | 8 | 8 |
2018 July | 0 | 3 | 3 |
2018 June | 0 | 1 | 1 |
2018 March | 0 | 1 | 1 |
2018 January | 0 | 1 | 1 |
2017 December | 0 | 1 | 1 |
2017 October | 4 | 1 | 5 |
2017 September | 8 | 3 | 11 |
2017 August | 6 | 5 | 11 |
2017 July | 10 | 0 | 10 |
2017 June | 17 | 3 | 20 |
2017 May | 12 | 5 | 17 |
2017 April | 8 | 23 | 31 |
2017 March | 21 | 3 | 24 |
2017 February | 21 | 1 | 22 |
2017 January | 4 | 2 | 6 |
2016 December | 32 | 5 | 37 |
2016 November | 53 | 2 | 55 |
2016 October | 82 | 2 | 84 |
2016 September | 44 | 2 | 46 |
2016 August | 10 | 2 | 12 |
2016 July | 5 | 1 | 6 |